Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03837249 · ClinicalTrials.gov registry record · Early Phase 1
Self-Management of Sleep Among Older Adults
A Early Phase 1 study, sponsored by University of Massachusetts, Amherst.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 26
- Enrollment target
NCT03837249: Completed Early Phase 1 study, sponsored by University of Massachusetts, Amherst.
NCT03837249 is a Early Phase 1 study that has completed, run by University of Massachusetts, Amherst. The registered enrollment target is 26 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (51% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03837249, a Early Phase 1 study, has completed, sponsored by University of Massachusetts, Amherst.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to test the feasibility of older persons use of a personal sleep monitoring device(PSMD)to improve self-management of sleep. Disrupted sleep occurs in up to 50% of persons over the age of 65 with chronic health conditions. Impaired sleep negatively influences subjective and objective health outcomes.To improve their sleep, older adults with chronic health conditions could benefit from objective information, available through personal health monitoring devices, about their current and changing sleep patterns. Based on this information, sleep self-management interventions can be individualized and shared, and associations between sleep and health changes may be better managed.
Primary Outcome
Demonstrates use of Personal Sleep Self-Monitor through data downloads and self-report
Interventions
- DEVICE Personal Sleep Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2019-02-04 |
| Est. Completion | 2020-01-30 |
| Phase | Early Phase 1 |
What the finished NCT03837249 record still lists
NCT03837249 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (51% lower).
The record links to 0 conditions, and to 1 intervention - of which Personal Sleep Monitoring is the first listed.
NCT03837249 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03837249 about?
NCT03837249 is a clinical study titled "Self-Management of Sleep Among Older Adults". The purpose of this study is to test the feasibility of older persons use of a personal sleep monitoring device(PSMD)to improve self-management of sleep. Disrupted sleep occurs in up to 50% of persons over the age of 65 with chronic health conditions. Impaired sleep negatively influences subjective ...
What is the current status of trial NCT03837249?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 26 participants. The study started on 2019-02-04. Estimated completion is 2020-01-30.
What interventions are being tested in trial NCT03837249?
The interventions under investigation include: Personal Sleep Monitoring (DEVICE).
Who is sponsoring clinical trial NCT03837249?
This trial is sponsored by University of Massachusetts, Amherst, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03837249's enrollment target sits among peer trials
26 977th of 2000 higher than 1,001 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI